Recombinant Protein Spectral Library (rPSL) DIA-MS method improves identification and quantification of low-abundance cancer-associated and kynurenine pathway proteins
Data-independent acquisition mass spectrometry (DIA-MS) is a powerful tool for quantitative proteomics, but a well-constructed reference spectral library is crucial to optimize DIA analysis, particularly for low-abundance proteins. In this study, we evaluate the efficacy of a recombinant protein spectral library (rPSL), generated from tryptic digestion of 42 human recombinant proteins, in enhancing the detection and quantification of lower-abundance cancer-associated proteins. Additionally, we generated a combined sample-specific biological-rPSL by integrating the rPSL with a spectral library derived from pooled biological samples. We compared the performance of these libraries for DIA data extraction with standard methods, including sample-specific biological spectral library and library-free DIA methods. Our specific focus was on quantifying cancer-associated proteins, including key enzymes involved in kynurenine pathway, across patient-derived tissues and cell lines. Both rPSL and biological-rPSL-DIA approaches provided significantly improved coverage of lower-abundance proteins, enhancing sensitivity and more consistent protein quantification across matched tumour and adjacent noncancerous tissues from breast and colorectal cancer patients and in cancer cell lines. Overall, our study demonstrates that rPSL and biological-rPSL coupled with DIA-MS workflows, can address the limitations of both biological library-based and library-free DIA methods, offering a robust approach for quantifying low-abundance cancer-associated proteins in complex biological samples.
Authors
- Shivani Krishnamurthy (ORCID: https://orcid.org/0000-0002-7418-4338)
- Laurence Gluch
- Joo‐Shik Shin (ORCID: https://orcid.org/0000-0001-7840-3625)
- Moumita Paul-Heng (ORCID: https://orcid.org/0000-0002-2134-6890)
- Benjamin Heng (ORCID: https://orcid.org/0000-0002-0247-2920)
- Seong Beom Ahn (ORCID: https://orcid.org/0000-0001-5907-3544)
- Bavani Gunasegaran (ORCID: https://orcid.org/0000-0002-4783-8404)
- William P. Klare (ORCID: https://orcid.org/0000-0002-1490-9704)
- Mark S. Baker (ORCID: https://orcid.org/0000-0001-5858-4035)
- Chi Nam Ignatius Pang (ORCID: https://orcid.org/0000-0001-9703-5741)
- Abidali Mohamedali (ORCID: https://orcid.org/0000-0001-5627-4105)
- Charles Chan (ORCID: https://orcid.org/0000-0003-3048-1514)
Institutions
- The University of Sydney (AU)
- Concord Hospital (US)
- Stratasys (Israel) (IL)
- Royal Prince Alfred Hospital (AU)
- Concord Repatriation General Hospital (AU)
- AGRF Ltd (AU)
- Macquarie University (AU)
Publication Details
- Journal
- Communications Chemistry
- Published
- 2025-05-10
- DOI
- https://doi.org/10.1038/s42004-025-01531-0
- Citations
- 3
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.73
Funders
- Macquarie University